Three pharmaceutical firms to jointly develop new antiviral drugs

Pacific Pharm, Pacific Co. and Entopharm, a bioventure firm, established their strategic alliances on March 27 for the joint development of alloferon, a lead compound discovered by Entopharm, for the treatment of hepatitis B and C. Following the commercialization of alloferon, Pacific Pharm is to get its exclusive marketing right in Korea.

Entopharm solidifies an extensive research network i...